ES2105959B1 - Derivados de 1,4-dioxido de quinoxalina, procedimiento de preparacion y de utilizacion. - Google Patents

Derivados de 1,4-dioxido de quinoxalina, procedimiento de preparacion y de utilizacion.

Info

Publication number
ES2105959B1
ES2105959B1 ES9500076A ES9500076A ES2105959B1 ES 2105959 B1 ES2105959 B1 ES 2105959B1 ES 9500076 A ES9500076 A ES 9500076A ES 9500076 A ES9500076 A ES 9500076A ES 2105959 B1 ES2105959 B1 ES 2105959B1
Authority
ES
Spain
Prior art keywords
derivatives
formula
dinoxide
quinoxaline
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES9500076A
Other languages
English (en)
Other versions
ES2105959A1 (es
Inventor
Vega Antonio Monge
Andy J Barker
Elizabeth Hamilton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca SAS
Original Assignee
Zeneca Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Pharma SA filed Critical Zeneca Pharma SA
Priority to ES9500076A priority Critical patent/ES2105959B1/es
Priority to GB9600963A priority patent/GB2297089B/en
Publication of ES2105959A1 publication Critical patent/ES2105959A1/es
Application granted granted Critical
Publication of ES2105959B1 publication Critical patent/ES2105959B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/50—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
    • C07D241/52—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

DERIVADOS DE 1,4-DIOXIDO DE QUINOXALINA, PROCEDIMIENTO DE PREPARACION Y DE UTILIZACION. DICHOS DERIVADOS RESPONDEN A LA FORMULA 1 EN DONDE LOS DISTINTOS RADICALES TIENEN LOS SIGNIFICADOS OFRECIDOS EN LA DESCRIPCION Y SE OBTIENEN MEDIANTE REACCION DE UN COMPUESTO DE FORMULA 3 CON UN COMPUESTO DE FORMULA NH2-ALQUIL (1-6C)-N(A1) (A2) EN DONDE A1 Y A2 TIENEN EL SIGNIFICADO INDICADO EN LA DESCRIPCION. LOS COMPUESTOS DE FORMULA 1 SON DE UTILIDAD COMO AGENTES CITOTOXICOS PARA DESTRUIR SELECTIVAMENTE CELULAS HIPOXICAS TUMORALES EN MAMIFEROS.
ES9500076A 1995-01-17 1995-01-17 Derivados de 1,4-dioxido de quinoxalina, procedimiento de preparacion y de utilizacion. Expired - Fee Related ES2105959B1 (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ES9500076A ES2105959B1 (es) 1995-01-17 1995-01-17 Derivados de 1,4-dioxido de quinoxalina, procedimiento de preparacion y de utilizacion.
GB9600963A GB2297089B (en) 1995-01-17 1996-01-17 Derivatives of quinoxaline 1 4-dioxide procedure for their preparation and their employment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9500076A ES2105959B1 (es) 1995-01-17 1995-01-17 Derivados de 1,4-dioxido de quinoxalina, procedimiento de preparacion y de utilizacion.

Publications (2)

Publication Number Publication Date
ES2105959A1 ES2105959A1 (es) 1997-10-16
ES2105959B1 true ES2105959B1 (es) 1998-07-01

Family

ID=8289176

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9500076A Expired - Fee Related ES2105959B1 (es) 1995-01-17 1995-01-17 Derivados de 1,4-dioxido de quinoxalina, procedimiento de preparacion y de utilizacion.

Country Status (2)

Country Link
ES (1) ES2105959B1 (es)
GB (1) GB2297089B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2278244A1 (en) * 1997-01-21 1998-07-23 Nissan Chemical Industries, Ltd. Industrial antimicrobial/mildew-proofing agents, algicides and antifouling agents containing n-quinoxalylanilines
HU229875B1 (en) 1999-01-11 2014-11-28 Agouron Pharmaceuticals Inc La Jolla Tricyclic inhibitors of poly(adp-ribose) polymerases
ECSP003637A (es) 1999-08-31 2002-03-25 Agouron Pharma Inhibidores triciclicos de poli (adp-ribosa) polimerasas
US7122571B2 (en) 2001-12-10 2006-10-17 Temple University - Of The Commonwealth System Of Higher Education Substituted hydrazones as inhibitors of cyclooxygenase-2
JP2006241111A (ja) * 2005-03-04 2006-09-14 Univ Nihon 新規ベンゾフロキサン及びその合成法
JP5190873B2 (ja) * 2005-10-14 2013-04-24 学校法人日本大学 マイクロ波照射によるキノキサリン誘導体の合成方法
WO2015167350A1 (ru) 2014-04-28 2015-11-05 Общество С Ограниченной Ответственностью "А-Лаборатория" Способ лечения опухолевого заболевания и способ селективного ингибирования роста опухолевых клеток с помощью производного хиноксалин-1,4-диоксида

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4343942A (en) * 1966-11-08 1982-08-10 Research Corporation Quinoxaline derivatives
US4822845A (en) * 1987-04-13 1989-04-18 The Firestone Tire & Rubber & Company Rubber compositions modified with heterocyclic di-N-oxides

Also Published As

Publication number Publication date
ES2105959A1 (es) 1997-10-16
GB9600963D0 (en) 1996-03-20
GB2297089B (en) 1998-08-26
GB2297089A (en) 1996-07-24

Similar Documents

Publication Publication Date Title
GT199900070A (es) Derivados de isotiazol, utiles como agentes anticancerosos.
PT1093819E (pt) Compostos e composicoes para fornecimento de agentes activos
AR010062A1 (es) Nuevos benzamidaldehidos y su utilizacion
BG103805A (en) Trifluoromethylalkylaminotriazolopyrimidines with fungicidal effect
BG104056A (en) Triazole compounds and their use as dopamine-d3-ligands
ES2094141T3 (es) 1h-imidazo(4,5-c)quinolin-4-aminas como antivirales.
NO20010228L (no) Farmasøytiske preparater omfattende 2-kinoloner
HK1088845A1 (en) Use of parthenolide derivatives as antileukemic and cytotoxic agents
BG103310A (en) Benzonaphthyridins as bronchial therapeutical means
SE9702564D0 (sv) New compounds
CA2153775A1 (en) Potentiation of Temozolomide in Human Tumour Cells
MY105344A (en) New sulphonyl compounds
ES2081635T3 (es) 5,6-dihidroxiindolinas como aditivos para recetas de tinte para el cabello.
ES2193246T3 (es) Cefalosporinas antibacterianas.
ES2105959B1 (es) Derivados de 1,4-dioxido de quinoxalina, procedimiento de preparacion y de utilizacion.
BR0115121A (pt) Compostos n-((1,2,4)triazoloazinil)tiofenossulfonamida como herbicidas
TR199700261A2 (xx) Yeni Pirimido (1,2-a) indoller.
ES2061811T3 (es) Uso de compuestos de gamma-oxibutenolido conjugados para tratar ulcera.
ES2082894T3 (es) Dihidropirido(4,3-d)pirimidinas 4-sustituidas como analgesicos y agentes antiinflamatorios topicos para el tratamiento de enfermedades de la piel.
BR0309996A (pt) Composto, composição farmacêutica, método de tratar ou melhorar doenças ou condições proliferativas, uso de um composto, e, método de tratar ou melhorar doenças inflamatórias
CO5011066A1 (es) Compuestos de triazina
AR008860A1 (es) Empleo de 1-hidroxi-2-piridonas para el tratamiento de la dermatitis seborreica
ES2063879T3 (es) Compuestos triacinicos.
TR199600316A1 (tr) Antiaritmik ve kardioprotektiv ikame edilmis indenoilguanidler.
PT1040820E (pt) Composicoes cosmeticas anti-solares a base de uma mistura sinergica de filtros esua utilizacoes

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19971016

Kind code of ref document: A1

Effective date: 19971016

FD1A Patent lapsed

Effective date: 20040503